Cargando…
BetaEval Global: Prospective, Multinational, Observational Cohort Study of Patients Using BETACONNECT(®)
PURPOSE: Patients with multiple sclerosis (MS) would benefit from continued long-term treatment with disease-modifying therapies, and autoinjectors may help improve patients’ satisfaction with therapy, thereby increasing adherence rates. BETACONNECT(®) is an autoinjector for interferon beta-1b desig...
Autores principales: | Patti, Francesco, Martínez Ginés, María Luisa, Norenberg, Christiane, Duarte Caron, Fernando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196206/ https://www.ncbi.nlm.nih.gov/pubmed/32425509 http://dx.doi.org/10.2147/PPA.S245955 |
Ejemplares similares
-
Adherence, satisfaction and functional health status among patients with multiple sclerosis using the BETACONNECT® autoinjector: a prospective observational cohort study
por: Kleiter, Ingo, et al.
Publicado: (2017) -
Patient satisfaction with the BETACONNECT™ autoinjector for interferon beta-1b
por: Weller, Ivonne, et al.
Publicado: (2015) -
Patient Satisfaction with the New Interferon Beta-1b Autoinjector (BETACONNECT™)
por: Ziemssen, Tjalf, et al.
Publicado: (2015) -
A Prospective, Observational, Multicenter Study Assessing Adherence to Interferon Beta-1b Therapy and Patient Satisfaction Using the BETACONNECT Auto-Injector
por: Farej, Ryan, et al.
Publicado: (2022) -
Predictors of Adherence Among Patients With Multiple Sclerosis Using the BETACONNECT(®) Autoinjector: A Prospective Observational Cohort Study
por: Köhler, Wolfgang, et al.
Publicado: (2021)